The DEtermining Statin Intolerance FOr Rosuvastatin (DESIFOR) Trial
Public ClinicalTrials.gov record NCT03889314. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will enroll patients who previously were not able to tolerate being on a statin medication due to muscle-related side effects. Research has shown that many people who have muscle symptoms on statin therapy do not experience the same side effects if they try it again later. This study is part of a larger effort to: * See how common it is for patients to still be intolerant of statin medication after trying it a second time; and * For those patients who do tolerate being on a statin after trying it a second time, see how common it is for them to still be taking the statin 3 months after completing the main part of the study. Patients who agree to participate will be given a 5 month randomly allocated supply of statin and placebo and track their symptoms weekly.
Study identification
- NCT ID
- NCT03889314
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 25 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 21 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 25, 2019
- Primary completion
- Dec 30, 2022
- Completion
- Dec 30, 2022
- Last update posted
- Mar 20, 2022
2019 – 2022
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Minneapolis Heart Institute Foundation | Minneapolis | Minnesota | 55407 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Cardiovascular Risk Factor trials
Other public records listing Cardiovascular Risk Factor. Sorted by last update posted; newest first. Not a recommendation.
- NCT07783061: Reducing Cardiovascular Risks: The Role of Alcohol Use Not yet recruiting
- NCT04804124: Sleep Duration and Cardiovascular Health Recruiting
- NCT03388788: Body Weight, Sleep, and Heart Health Active, not recruiting
- NCT05887622: The Potassium Supplementation Study Active, not recruiting
- NCT04101188: Mechanisms Underlying the Protective Vascular Effects of Dietary Potassium in Humans Recruiting
- NCT03480633: Biomechanical Precision Medicine Registry for Patients With and Without Heart Failure Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03889314, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 20, 2022 · Synced Sep 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03889314 live on ClinicalTrials.gov.